ICU Medical (ICUI) revenue breakdown

Healthcare · Medical Instruments & Supplies · Market cap $4.3B

By product, Infusion Consumables is the largest at 50% of fiscal 2025 revenue, growing 15% a year over 9 years.

By region, UNITED STATES is the largest at 61% of fiscal 2025 revenue; APAC grew fastest, 24% a year over 5 years.

Revenue by product

Fiscal years, as ICU Medical reports them in its 10-K filings; fiscal 2025 total $2.2B.

Products2016201720182019202020212022202320242025Share
Infusion Consumables$325M$366M$483M$478M$474M$555M$975M$969M$1.0B$1.1B 50%
Infusion Systems—$290M$355M$328M$360M$352M$617M$629M$652M$684M 31%
Vital Care—————$409M$688M$661M$691M$438M 20%
IV Solutions—$522M$508M$415M$389M————— —
Other Revenue—$65M———————— —
Critical Care$54M$50M$54M$45M$49M————— —
Other Revenue$903,000————————— —

Revenue by region

Fiscal years, as ICU Medical reports them in its 10-K filings; fiscal 2025 total $2.2B.

Regions2016201720182019202020212022202320242025Share
UNITED STATES$262M$980M$1.1B$923M$911M$942M$1.5B$1.4B$1.5B$1.4B 61%
EMEA———$131M$133M$147M$367M$374M$394M$412M 18%
APAC————$80M$86M$257M$242M$233M$233M 10%
Other foreign countries———$212M$148M$141M$195M$204M$224M$231M 10%
Foreign$118M$313M$345M——————— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ICUI.
Open ICUI in Investingly

Questions

Where does ICU Medical make its money?

In fiscal 2025, by product: Infusion Consumables $1.1B, Infusion Systems $684M, Vital Care $438M.

From ICU Medical's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.